{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T16:06:01Z","timestamp":1779811561798,"version":"3.53.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171834"],"award-info":[{"award-number":["82171834"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573671"],"award-info":[{"award-number":["82573671"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Province Seventh 333 High Level (Second Level) Talents Project","award":["Jiangsu Province Seventh 333 High Level (Second Level) Talents Project"],"award-info":[{"award-number":["Jiangsu Province Seventh 333 High Level (Second Level) Talents Project"]}]},{"name":"Suzhou Science and Technology Development Plan Project","award":["SKY2023049"],"award-info":[{"award-number":["SKY2023049"]}]},{"name":"Provincial-level talent program for National center of technology innovation for bio pharmaceuticals","award":["NCTIB2024JS0101"],"award-info":[{"award-number":["NCTIB2024JS0101"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13304-025-02505-6","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T19:31:09Z","timestamp":1768332669000},"page":"695-704","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcatheter arterial chemoembolization plus ablation therapy versus liver resection for hepatocellular carcinoma with clinically significant portal hypertension by an inverse probability of treatment weighting analysis"],"prefix":"10.1007","volume":"78","author":[{"given":"Ming-Cheng","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"2505_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"2505_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H et al (2024) Cancer incidence and mortality in China, 2022. J Natl Cancer Cent 4:47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006","journal-title":"J Natl Cancer Cent"},{"key":"2505_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver (2018) Electronic address eee, European association for the study of the L. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 69:182\u2013236. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.019","journal-title":"J Hepatol"},{"key":"2505_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cld.2013.12.001","volume":"18","author":"Y Iwakiri","year":"2014","unstructured":"Iwakiri Y (2014) Pathophysiology of portal hypertension. Clin Liver Dis 18:281\u2013291. https:\/\/doi.org\/10.1016\/j.cld.2013.12.001","journal-title":"Clin Liver Dis"},{"key":"2505_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","volume":"6","author":"J Bosch","year":"2009","unstructured":"Bosch J, Abraldes JG, Berzigotti A, Garcia-Pagan JC (2009) The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 6:573\u2013582. https:\/\/doi.org\/10.1038\/nrgastro.2009.149","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2505_CR6","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1007\/s00330-017-5145-9","volume":"28","author":"JW Choi","year":"2018","unstructured":"Choi JW, Chung JW, Lee DH et al (2018) Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma. Eur Radiol 28:2184\u20132193. https:\/\/doi.org\/10.1007\/s00330-017-5145-9","journal-title":"Eur Radiol"},{"key":"2505_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ueg2.12188","volume":"10","author":"L Muller","year":"2022","unstructured":"Muller L, Hahn F, Mahringer-Kunz A et al (2022) Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. United Eur Gastroenterol J 10:41\u201353. https:\/\/doi.org\/10.1002\/ueg2.12188","journal-title":"United Eur Gastroenterol J"},{"key":"2505_CR8","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1007\/s00464-020-07763-6","volume":"35","author":"J Zheng","year":"2021","unstructured":"Zheng J, Feng X, Liang Y et al (2021) Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study. Surg Endosc 35:3267\u20133278. https:\/\/doi.org\/10.1007\/s00464-020-07763-6","journal-title":"Surg Endosc"},{"key":"2505_CR9","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s11605-018-3981-9","volume":"23","author":"Y Pei","year":"2019","unstructured":"Pei Y, Chai S, Zhang Y et al (2019) Benefits of splenectomy and curative treatments for patients with hepatocellular carcinoma and portal hypertension: a retrospective study. J Gastrointest Surg 23:2151\u20132162. https:\/\/doi.org\/10.1007\/s11605-018-3981-9","journal-title":"J Gastrointest Surg"},{"key":"2505_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00464-023-10591-z","volume":"38","author":"H Shinkawa","year":"2024","unstructured":"Shinkawa H, Kaibori M, Kabata D et al (2024) Laparoscopic and open minor liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a multicenter study using inverse probability weighting approach. Surg Endosc 38:757\u2013768. https:\/\/doi.org\/10.1007\/s00464-023-10591-z","journal-title":"Surg Endosc"},{"key":"2505_CR11","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1148\/radiol.13130387","volume":"269","author":"Y Takuma","year":"2013","unstructured":"Takuma Y, Takabatake H, Morimoto Y et al (2013) Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria. Radiology 269:927\u2013937. https:\/\/doi.org\/10.1148\/radiol.13130387","journal-title":"Radiology"},{"key":"2505_CR12","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s12094-016-1611-0","volume":"19","author":"AK Bholee","year":"2017","unstructured":"Bholee AK, Peng K, Zhou Z et al (2017) Radiofrequency ablation combined with transarterial chemoembolization versus hepatectomy for patients with hepatocellular carcinoma within Milan criteria: a retrospective case-control study. Clin Transl Oncol 19:844\u2013852. https:\/\/doi.org\/10.1007\/s12094-016-1611-0","journal-title":"Clin Transl Oncol"},{"key":"2505_CR13","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jvir.2018.09.030","volume":"30","author":"HJ Lee","year":"2019","unstructured":"Lee HJ, Kim JW, Hur YH et al (2019) Conventional chemoembolization plus radiofrequency ablation versus surgical resection for Single, Medium-Sized hepatocellular carcinoma: propensity-Score matching analysis. J Vasc Interv Radiol 30:284\u201392e1. https:\/\/doi.org\/10.1016\/j.jvir.2018.09.030","journal-title":"J Vasc Interv Radiol"},{"key":"2505_CR14","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1007\/s00330-023-10268-0","volume":"34","author":"H Yu","year":"2024","unstructured":"Yu H, Zhao F, Men X et al (2024) Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension: a propensity score-matched study of postoperative liver decompensation. Eur Radiol 34:3226\u20133235. https:\/\/doi.org\/10.1007\/s00330-023-10268-0","journal-title":"Eur Radiol"},{"key":"2505_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1478-3231.2010.02436.x","volume":"31","author":"GH Choi","year":"2011","unstructured":"Choi GH, Park JY, Hwang HK et al (2011) Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma. Liver Int 31:485\u2013493. https:\/\/doi.org\/10.1111\/j.1478-3231.2010.02436.x","journal-title":"Liver Int"},{"key":"2505_CR16","doi-asserted-by":"publisher","first-page":"100190","DOI":"10.1016\/j.jhepr.2020.100190","volume":"3","author":"D Azoulay","year":"2021","unstructured":"Azoulay D, Ramos E, Casellas-Robert M et al (2021) Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension. JHEP Rep 3:100190. https:\/\/doi.org\/10.1016\/j.jhepr.2020.100190","journal-title":"JHEP Rep"},{"key":"2505_CR17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s12672-025-02274-z","volume":"16","author":"Q Zeng","year":"2025","unstructured":"Zeng Q, Wang X, Liu J et al (2025) Application of machine learning models to explore prognosis and cause of death in advanced intrahepatic cholangiocarcinoma patients undergoing chemotherapy. Discov Oncol 16:490. https:\/\/doi.org\/10.1007\/s12672-025-02274-z","journal-title":"Discov Oncol"},{"key":"2505_CR18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.14218\/JCTH.2021.00593","volume":"10","author":"SHH Nababan","year":"2022","unstructured":"Nababan SHH, Lesmana CRA (2022) Portal hypertension in nonalcoholic fatty liver disease: from pathogenesis to clinical practice. J Clin Transl Hepatol 10:979\u2013985. https:\/\/doi.org\/10.14218\/JCTH.2021.00593","journal-title":"J Clin Transl Hepatol"},{"key":"2505_CR19","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.jceh.2022.04.021","volume":"12","author":"M Premkumar","year":"2022","unstructured":"Premkumar M, Anand AC (2022) Overview of complications in cirrhosis. J Clin Exp Hepatol 12:1150\u20131174. https:\/\/doi.org\/10.1016\/j.jceh.2022.04.021","journal-title":"J Clin Exp Hepatol"},{"key":"2505_CR20","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/hep.27343","volume":"61","author":"M Fernandez","year":"2015","unstructured":"Fernandez M (2015) Molecular pathophysiology of portal hypertension. Hepatology 61:1406\u20131415. https:\/\/doi.org\/10.1002\/hep.27343","journal-title":"Hepatology"},{"key":"2505_CR21","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.cgh.2006.09.009","volume":"4","author":"P Tandon","year":"2006","unstructured":"Tandon P, Garcia-Tsao G (2006) Portal hypertension and hepatocellular carcinoma: prognosis and beyond. Clin Gastroenterol Hepatol 4:1318\u20131319. https:\/\/doi.org\/10.1016\/j.cgh.2006.09.009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2505_CR22","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1007\/s00268-005-0524-9","volume":"30","author":"L Capussotti","year":"2006","unstructured":"Capussotti L, Ferrero A, Vigano L et al (2006) Portal hypertension: contraindication to liver surgery? World J Surg 30:992\u2013999. https:\/\/doi.org\/10.1007\/s00268-005-0524-9","journal-title":"World J Surg"},{"key":"2505_CR23","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/SLA.0b013e3181b977a5","volume":"250","author":"A Cucchetti","year":"2009","unstructured":"Cucchetti A, Ercolani G, Vivarelli M et al (2009) Is portal hypertension a contraindication to hepatic resection? Ann Surg 250:922\u2013928. https:\/\/doi.org\/10.1097\/SLA.0b013e3181b977a5","journal-title":"Ann Surg"},{"key":"2505_CR24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/hep.27431","volume":"61","author":"A Berzigotti","year":"2015","unstructured":"Berzigotti A, Reig M, Abraldes JG et al (2015) Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology 61:526\u2013536. https:\/\/doi.org\/10.1002\/hep.27431","journal-title":"Hepatology"},{"key":"2505_CR25","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"R European Organisation For","year":"2012","unstructured":"European Association For The Study Of The L, European Organisation For R, Treatment Of C (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908\u2013943. https:\/\/doi.org\/10.1016\/j.jhep.2011.12.001","journal-title":"J Hepatol"},{"key":"2505_CR26","doi-asserted-by":"publisher","first-page":"107073","DOI":"10.1016\/j.ejso.2023.107073","volume":"49","author":"Z Lu","year":"2023","unstructured":"Lu Z, Wei X, Tan L et al (2023) Is hepatectomy feasible for hepatocellular carcinoma patients with clinically significant portal hypertension and beyond the Milan criteria? Eur J Surg Oncol 49:107073. https:\/\/doi.org\/10.1016\/j.ejso.2023.107073","journal-title":"Eur J Surg Oncol"},{"key":"2505_CR27","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1111\/jgh.14083","volume":"33","author":"NH Kim","year":"2018","unstructured":"Kim NH, Lee T, Cho YK et al (2018) Impact of clinically evident portal hypertension on clinical outcome of patients with hepatocellular carcinoma treated by transarterial chemoembolization. J Gastroenterol Hepatol 33:1397\u20131406. https:\/\/doi.org\/10.1111\/jgh.14083","journal-title":"J Gastroenterol Hepatol"},{"key":"2505_CR28","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1007\/s00330-016-4604-z","volume":"27","author":"KC Fang","year":"2017","unstructured":"Fang KC, Su CW, Chiou YY et al (2017) The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation: a propensity score matching analysis. Eur Radiol 27:2600\u20132609. https:\/\/doi.org\/10.1007\/s00330-016-4604-z","journal-title":"Eur Radiol"},{"key":"2505_CR29","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.1002\/cncr.25314","volume":"116","author":"M Morimoto","year":"2010","unstructured":"Morimoto M, Numata K, Kondou M et al (2010) Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer 116:5452\u20135460. https:\/\/doi.org\/10.1002\/cncr.25314","journal-title":"Cancer"},{"key":"2505_CR30","doi-asserted-by":"publisher","first-page":"e2126992","DOI":"10.1001\/jamanetworkopen.2021.26992","volume":"4","author":"YJ Zhang","year":"2021","unstructured":"Zhang YJ, Chen MS, Chen Y et al (2021) Long-term outcomes of transcatheter arterial chemoembolization combined with radiofrequency ablation as an initial treatment for Early-Stage hepatocellular carcinoma. JAMA Netw Open 4:e2126992. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.26992","journal-title":"JAMA Netw Open"},{"key":"2505_CR31","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1200\/JCO.2012.42.9936","volume":"31","author":"ZW Peng","year":"2013","unstructured":"Peng ZW, Zhang YJ, Chen MS et al (2013) Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol 31:426\u2013432. https:\/\/doi.org\/10.1200\/JCO.2012.42.9936","journal-title":"J Clin Oncol"},{"key":"2505_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10033-015-0125-y","volume":"1","author":"X Chen","year":"2015","unstructured":"Chen X, Zhang B (2015) Combined treatment is the hope to improve prognosis of liver cancer. Oncol Translational Med 1:241\u2013242","journal-title":"Oncol Translational Med"},{"key":"2505_CR33","doi-asserted-by":"publisher","first-page":"e29321","DOI":"10.1097\/MD.0000000000029321","volume":"101","author":"Z Dou","year":"2022","unstructured":"Dou Z, Lu F, Ren L et al (2022) Efficacy and safety of microwave ablation and radiofrequency ablation in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Med (Baltim) 101:e29321. https:\/\/doi.org\/10.1097\/MD.0000000000029321","journal-title":"Med (Baltim)"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02505-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-025-02505-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02505-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:39:54Z","timestamp":1779809994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-025-02505-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2505"],"URL":"https:\/\/doi.org\/10.1007\/s13304-025-02505-6","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest related to this publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}